Maniform episode related to memantine therapy: unraveling of an unknown adverse side effect?
Introduction: Memantine, a type of N-methyl-D-aspartate (NMDA) antagonist, is a drug approved by Food and Drug Administration to the treatment of moderate-to-severe Alzheimer disease (AD). Glutamate has been hypothesized to be released in excess in AD, perhaps in part triggered by neurotoxic amyloi...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Instituto Psiquiatría Psicodex SL
2021-08-01
|
| Series: | Psicosomática y Psiquiatría |
| Subjects: | |
| Online Access: | https://raco.cat/index.php/PsicosomPsiquiatr/article/view/391354 |